• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人血液中循环的糖基化N末端脑钠肽前体的免疫检测

Immunodetection of glycosylated NT-proBNP circulating in human blood.

作者信息

Seferian Karina R, Tamm Natalia N, Semenov Alexander G, Tolstaya Anastasia A, Koshkina Ekaterina V, Krasnoselsky Mihail I, Postnikov Alexander B, Serebryanaya Daria V, Apple Fred S, Murakami MaryAnn M, Katrukha Alexey G

机构信息

HyTest Ltd., Turku, Finland.

出版信息

Clin Chem. 2008 May;54(5):866-73. doi: 10.1373/clinchem.2007.100040. Epub 2008 Mar 13.

DOI:10.1373/clinchem.2007.100040
PMID:18339697
Abstract

BACKGROUND

Brain natriuretic peptide (BNP) or NT-proBNP (N-terminal fragment of BNP precursor) measurements are recommended as aids in diagnosis and prognosis of patients with heart failure. Recently it has been shown that proBNP is O-glycosylated in human blood. The goal of this study was to map sites on the NT-proBNP molecule that should be recognized by antibodies used in optimal NT-proBNP assays.

METHODS

We analyzed endogenous NT-proBNP by several immunochemical methods using a broad panel of monoclonal antibodies specific to different epitopes of the NT-proBNP molecule.

RESULTS

Treatment of endogenous NT-proBNP by a mixture of glycosidases resulted in significant improvement of the interaction between deglycosylated NT-proBNP and monoclonal antibodies (MAbs) specific to the mid-fragment of the molecule. MAbs specific to the N- and C-terminal parts of NT-proBNP (epitopes 13-24 and 63-76) were able to recognize glycosylated and deglycosylated protein with similar efficiency.

CONCLUSIONS

The central part of endogenous NT-proBNP is glycosylated, making it almost "invisible" for the antibodies specific to the mid-fragment of the molecule. Thus sandwich assays using even one antibody (poly- or monoclonal) specific to the central part of the molecule could underestimate the real concentration of endogenous NT-proBNP. MAbs specific to the N- and C-terminal parts of NT-proBNP (epitopes 13-24 and 63-76) are the best candidates to be used in an assay for optimal NT-proBNP immunodetection.

摘要

背景

脑钠肽(BNP)或NT-proBNP(BNP前体的N端片段)检测被推荐用于辅助心力衰竭患者的诊断和预后评估。最近有研究表明,proBNP在人体血液中发生了O-糖基化修饰。本研究的目的是确定NT-proBNP分子上那些在最佳NT-proBNP检测中应被抗体识别的位点。

方法

我们使用了一组针对NT-proBNP分子不同表位的单克隆抗体,通过多种免疫化学方法分析内源性NT-proBNP。

结果

用糖苷酶混合物处理内源性NT-proBNP后,去糖基化的NT-proBNP与针对该分子中段的单克隆抗体(MAbs)之间的相互作用显著改善。针对NT-proBNP N端和C端部分(表位13 - 24和63 - 76)的MAbs能够以相似的效率识别糖基化和去糖基化的蛋白。

结论

内源性NT-proBNP的中央部分发生了糖基化修饰,这使得它对于针对该分子中段的抗体几乎“不可见”。因此,即使使用一种针对该分子中央部分的抗体(多克隆或单克隆)进行夹心检测,也可能低估内源性NT-proBNP的实际浓度。针对NT-proBNP N端和C端部分(表位13 - 24和63 - 76)的MAbs是用于最佳NT-proBNP免疫检测的最佳候选抗体。

相似文献

1
Immunodetection of glycosylated NT-proBNP circulating in human blood.人血液中循环的糖基化N末端脑钠肽前体的免疫检测
Clin Chem. 2008 May;54(5):866-73. doi: 10.1373/clinchem.2007.100040. Epub 2008 Mar 13.
2
The brain natriuretic peptide (BNP) precursor is the major immunoreactive form of BNP in patients with heart failure.脑钠肽(BNP)前体是心力衰竭患者体内BNP的主要免疫反应形式。
Clin Chem. 2007 May;53(5):866-73. doi: 10.1373/clinchem.2006.076141. Epub 2007 Mar 23.
3
Cutting Edge of Brain Natriuretic Peptide (BNP) Research - The Diversity of BNP Immunoreactivity and Its Clinical Relevance.脑利钠肽(BNP)研究的前沿 - BNP 免疫反应的多样性及其临床相关性。
Circ J. 2018 Sep 25;82(10):2455-2461. doi: 10.1253/circj.CJ-18-0824. Epub 2018 Aug 21.
4
Circulating fragments of N-terminal pro-B-type natriuretic peptides in plasma of heart failure patients.心力衰竭患者血浆中 N 末端 pro-B 型利钠肽原的循环片段。
Clin Chem. 2013 Oct;59(10):1523-31. doi: 10.1373/clinchem.2012.200204. Epub 2013 Jul 2.
5
Unraveling the Molecular Complexity of O-Glycosylated Endogenous (N-Terminal) pro-B-Type Natriuretic Peptide Forms in Blood Plasma of Patients with Severe Heart Failure.解析重度心力衰竭患者血浆中O-糖基化内源性(N端)B型利钠肽前体形式的分子复杂性
Clin Chem. 2017 Jan;63(1):359-368. doi: 10.1373/clinchem.2016.265397. Epub 2016 Nov 8.
6
Different Susceptibility of B-Type Natriuretic Peptide (BNP) and BNP Precursor (proBNP) to Cleavage by Neprilysin: The N-Terminal Part Does Matter.B型利钠肽(BNP)和BNP前体(proBNP)对中性内肽酶切割的不同敏感性:N端部分至关重要。
Clin Chem. 2016 Apr;62(4):617-22. doi: 10.1373/clinchem.2016.254524. Epub 2016 Feb 10.
7
The effect of glycosylation on plasma N-terminal proBNP-76 levels in patients with heart or renal failure.糖基化对心力衰竭或肾衰竭患者血浆 N 末端 proBNP-76 水平的影响。
Heart. 2012 Jan;98(2):152-61. doi: 10.1136/heartjnl-2011-300102. Epub 2011 Jun 30.
8
Processing of pro-brain natriuretic peptide is suppressed by O-glycosylation in the region close to the cleavage site.前脑钠肽在靠近裂解位点的区域的O-糖基化作用会抑制其加工过程。
Clin Chem. 2009 Mar;55(3):489-98. doi: 10.1373/clinchem.2008.113373. Epub 2009 Jan 23.
9
Standardization of BNP and NT-proBNP Immunoassays in Light of the Diverse and Complex Nature of Circulating BNP-Related Peptides.鉴于循环 BNP 相关肽的多样性和复杂性,BNP 和 NT-proBNP 免疫分析的标准化。
Adv Clin Chem. 2018;85:1-30. doi: 10.1016/bs.acc.2018.02.001. Epub 2018 Mar 3.
10
Combining the use of amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the prognosis of hospitalized heart failure patients.联合应用氨基末端 pro-B 型利钠肽原和 B 型利钠肽对心力衰竭住院患者预后的评估。
Clin Chim Acta. 2019 Apr;491:8-14. doi: 10.1016/j.cca.2018.12.025. Epub 2018 Dec 28.

引用本文的文献

1
Neprilysin 2 catalyses the degradation of natriuretic peptides despite sacubitrilat Inhibition.尽管有沙库巴曲缬沙坦抑制作用,中性肽链内切酶2仍催化利钠肽的降解。
Sci Rep. 2025 Jul 28;15(1):27401. doi: 10.1038/s41598-025-10166-z.
2
Method Evaluation of the QuidelOrtho Diagnostics Vitros NT-proBNP II Assay.QuidelOrtho诊断公司Vitros NT-proBNP II检测方法的评估
J Clin Med. 2024 Dec 19;13(24):7751. doi: 10.3390/jcm13247751.
3
Selection, alkaline phosphatase fusion, and application of single-chain variable fragment (scFv) specific to NT-proBNP as electrochemical immunosensor for heart failure.
用于心力衰竭的电化学免疫传感器——NT-proBNP特异性单链可变片段(scFv)的筛选、碱性磷酸酶融合及应用
Heliyon. 2023 Sep 1;9(9):e19710. doi: 10.1016/j.heliyon.2023.e19710. eCollection 2023 Sep.
4
Prognostic utility of serum NT-proBNP (fragments 1-76aa and 13-71aa) and galectin-3 in predicting death and re-hospitalisation due to cardiovascular events in patients with heart failure.心力衰竭患者血清 NT-proBNP(片段 1-76aa 和 13-71aa)和半乳糖凝集素-3 预测死亡和心血管事件再住院的预后价值。
Heart Vessels. 2024 Jan;39(1):86-94. doi: 10.1007/s00380-023-02296-z. Epub 2023 Aug 3.
5
FN3 Domain Displaying Double Epitopes: A Cost-Effective Strategy for Producing Substitute Antigens.展示双表位的FN3结构域:一种生产替代抗原的经济有效策略。
Front Mol Biosci. 2021 Nov 4;8:742617. doi: 10.3389/fmolb.2021.742617. eCollection 2021.
6
Impact of natriuretic peptide polymorphisms on diastolic and metabolic function in a populational cohort: insights from the STANISLAS cohort.利钠肽多态性对人群舒张功能和代谢功能的影响:来自 STANISLAS 队列的研究结果。
ESC Heart Fail. 2022 Feb;9(1):729-739. doi: 10.1002/ehf2.13674. Epub 2021 Nov 3.
7
NT-proBNP/BNP ratio for prognostication in European Caucasian patients enrolled in a heart failure prevention programme.用于预测欧洲白种人心衰预防计划入组患者预后的 NT-proBNP/BNP 比值。
ESC Heart Fail. 2021 Dec;8(6):5081-5091. doi: 10.1002/ehf2.13576. Epub 2021 Sep 29.
8
B-Type Natriuretic Peptide as a Significant Brain Biomarker for Stroke Triaging Using a Bedside Point-of-Care Monitoring Biosensor.B 型利钠肽作为床边即时检测生物传感器用于脑卒中分诊的重要脑生物标志物。
Biosensors (Basel). 2020 Aug 26;10(9):107. doi: 10.3390/bios10090107.
9
Cardiac natriuretic peptides.心脏利钠肽。
Nat Rev Cardiol. 2020 Nov;17(11):698-717. doi: 10.1038/s41569-020-0381-0. Epub 2020 May 22.
10
BNP/NT-proBNP in pulmonary arterial hypertension: time for point-of-care testing?在肺动脉高压中应用 BNP/NT-proBNP:即时检测的时机是否已到?
Eur Respir Rev. 2020 May 15;29(156). doi: 10.1183/16000617.0009-2020. Print 2020 Jun 30.